ESC 365 - Diagnostic and therapeutic Advances to Optimize Tricuspid Regurgitation management : the evidence.

Open Access

Diagnostic and therapeutic Advances to Optimize Tricuspid Regurgitation management : the evidence.

Session: Elevating the standard of valvular heart therapies: key role of the echocardiologist

Topic: Valvular Heart Disease

Speaker: Assistant Professor M. Taramasso (Zurich, CH)

Sponsored by Abbott Structural Heart

Event: EuroEcho 2021

Congress Presentation

Add to my library

About the speaker

Assistant Professor Maurizio Taramasso

University Hospital Zurich, Zurich (Switzerland)

3 presentations

0 follower

6 more presentations in this session

Introduction.

Speaker: Doctor M. Sitges (Barcelona, ES)

New ESC 2021 Guidelines Heart Failure & Valvular Heart Disease : what changed.

Speaker: Doctor M. Senni (Bergamo, IT)

Tailoring Transcatheter Mitral Regurgitation Treatment : the evidence.

Speaker: Professor R. von Bardeleben (Mainz, DE)

Tailoring Transcatheter Mitral Regurgitation Treatment : the Patient.

Speaker: Doctor M. Swaans (Nieuwegein, NL)

Diagnostic and therapeutic Advances to Optimize Tricuspid Regurgitation management : the Patient.

Speaker: Doctor M. Swaans (Nieuwegein, NL)

Access the full session

Elevating the standard of valvular heart therapies: key role of the echocardiologist

Speakers: Assistant Professor M. Taramasso, Doctor M. Sitges, Doctor M. Senni, Professor R. von Bardeleben, Doctor M. Swaans...

About the event

EuroEcho 2021

9 December - 11 December 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources